Pyridazine derivatives and their use as therapeutic agents
US7754711B2 · kind B2 · utility
1Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2005 |
| Grant date | Jul 13, 2010 |
| Priority date | — |
| Expiry date | Jun 4, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D237/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (Ia):where x, y, W, V, R2, R3, R4, R5, R6, R6a, R7, R7a, R8, R8a, R9 and R9a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.